# A Safety And Pharmacokinetic Study of Setrobuvir Alone and In Combination With Ritonavir-Boosted Danoprevir in Subjects With Mild Hepatic Impairment Compared to Healthy Controls

> **NCT01714154** · PHASE1 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 18 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** danoprevir
- **DRUG:** ritonavir
- **DRUG:** setrobuvir

## Key facts

- **NCT ID:** NCT01714154
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11
- **Primary completion:** 2013-05
- **Final completion:** 2013-05
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2016-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01714154

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01714154, "A Safety And Pharmacokinetic Study of Setrobuvir Alone and In Combination With Ritonavir-Boosted Danoprevir in Subjects With Mild Hepatic Impairment Compared to Healthy Controls". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01714154. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*